NEWS & EVENTS
2019
August 11, 2019
Patients Who Receive Positively Framed Biosimilar Information More Than Twice as Likely to Accept a Switch
July 19, 2019
Amgen and Allergan Launch Mvasi and Kanjinti, the First Anticancer Biosimilars, in the United States
March 12, 2019
Sagent Acquires US Facility for Biosimilar Production
January 3, 2019
January MedPAC Recommendations: Rebates & Biosimilars
2018
2017
November 16, 2017
Update: How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline
November 6, 2017
CMS Shift on Biosimilar Reimbursement Under Part B: What to Expect
October 23, 2017
FDA Taking New Steps to Better Inform Physicians about Biosimilars Through Education about these Potentially Cost-Saving Options
September 28, 2017
Marketing Approval for Infliximab Biosimilar 100mg “Nichi-Iko” in Japan